PierianDx Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 324

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 6

  • Investments
  • 1

PierianDx General Information

Description

Developer of a cloud-based clinical software designed to facilitate research on the sequencing testing process. The company's software uses artificial intelligence to automate the process of taking DNA sequencing data through analysis, interpretation and final report, thereby empowering physicians in the laboratory and clinic to effectively diagnose and treat patients with cancer and other complex diseases.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Biotechnology
Parent Company
Corporate Office
  • 6 Cityplace Drive
  • Suite 550
  • Creve Coeur, MO 63141
  • United States
+1 (314) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PierianDx Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PierianDx‘s full profile, request access.

Request a free trial

PierianDx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a cloud-based clinical software designed to facilitate research on the sequencing testing process. The comp
Decision/Risk Analysis
Creve Coeur, MO
324 As of 2023
000.00
000000000000 000.00

000000

sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad m
0000000000000 000000
Dublin, Ireland
000 As of 0000
00000
00000 0000-00-00
000000&0 00000

000000

piscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
0000000000000 000000
New York, NY
00 As of 0000
000.00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PierianDx Competitors (36)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genuity Science Formerly VC-backed Dublin, Ireland 000 00000 000000&0 00000
Phosphorus (Decision/Risk Analysis) Formerly VC-backed New York, NY 00 000.00 000000&0 000.00
Tempus Venture Capital-Backed Chicago, IL 0000 00.000 00000000 00.000
Fabric Genomics Venture Capital-Backed Oakland, CA 00 000.00 000000 - 000 000.00
Genomenon Venture Capital-Backed Ann Arbor, MI 000 000.00 00000000000 000.00
You’re viewing 5 of 36 competitors. Get the full list »

PierianDx Executive Team (19)

Name Title Board Seat Contact Info
Chris Callahan Executive Vice President
Mukesh Sharma Ph.D Vice President, Product
You’re viewing 2 of 19 executive team members. Get the full list »

PierianDx Board Members (14)

Name Representing Role Since
000000000 0000000 Self Board Member 000 0000
0000 0000000 00 Tute Genomics Board Member 000 0000
You’re viewing 2 of 14 board members. Get the full list »

PierianDx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PierianDx Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PierianDx‘s full profile, request access.

Request a free trial

PierianDx Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Tute Genomics 12-Oct-2016 0000000000 Social/Platform Software 000 00000
To view PierianDx’s complete acquisitions history, request access »

PierianDx FAQs

  • When was PierianDx founded?

    PierianDx was founded in 2014.

  • Who is the founder of PierianDx?

    Karen Seibert Ph.D, Rakesh Nagarajan Ph.D, and Jeffrey Milbrandt Ph.D are the founders of PierianDx.

  • Where is PierianDx headquartered?

    PierianDx is headquartered in Creve Coeur, MO.

  • What is the size of PierianDx?

    PierianDx has 324 total employees.

  • What industry is PierianDx in?

    PierianDx’s primary industry is Decision/Risk Analysis.

  • Is PierianDx a private or public company?

    PierianDx is a Private company.

  • What is PierianDx’s current revenue?

    The current revenue for PierianDx is 00000.

  • How much funding has PierianDx raised over time?

    PierianDx has raised $68.5M.

  • Who are PierianDx’s investors?

    ARUP Laboratories, ATW Partners, Album VC, Bodhi Capital, and Health Catalyst Capital Management are 5 of 15 investors who have invested in PierianDx.

  • Who are PierianDx’s competitors?

    Genuity Science, Phosphorus (Decision/Risk Analysis), Tempus, Fabric Genomics, and Genomenon are some of the 36 competitors of PierianDx.

  • When was PierianDx acquired?

    PierianDx was acquired on 01-Aug-2022.

  • Who acquired PierianDx?

    PierianDx was acquired by Velsera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »